• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

From cryptogenic to ESUS: Toward precision medicine?
Rev Neurol (Paris). 2022 May 18:S0035-3787(22)00592-6. doi: 10.1016/j.neurol.2022.01.016. Online ahead of print.ABSTRACTCryptogenic infarctions are infarctions without a defined cause, despite a complete work-up. They differ from infarctions of undetermined causes, which may involve overlapping causes or an incomplete investigation. It is also different from uncommon heritable and non-heritable causes. The term embolic stroke of undetermined source (ESUS) proposed in 2014 is defined as a non-lacunar brain infarct without proximal arterial stenosis or cardioembolic sources. The major advantage of this definition compared to...
Source: Revue Neurologique - May 21, 2022 Category: Neurology Authors: S Timsit Source Type: research

Atrial fibrillation in cancer patients who develop stroke
CONCLUSION: AF, previous ischemic stroke, active cancer treatment, dyslipidemia, and renal disease are independent risk factors for Stroke/TIA and a higher CHA2DS2-VASc score significantly increases the risk in cancer patients regardless of AF.PMID:35585638 | DOI:10.1186/s40959-022-00137-y
Source: Cancer Control - May 18, 2022 Category: Cancer & Oncology Authors: Alia Khamis Ala Emad Shaban Tamer Salhab Altamimi Zakaria Walid Shkoukani Ismail Hamam Source Type: research

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010 –2016
ConclusionsNearly 7 out of 10 patients with cancer and NVAF did not receive anticoagulation. Use of DOACs increased from 2010 to 2016, with a corresponding decline in warfarin use. DOACs are used less than warfarin among those at higher risk of stroke.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - May 6, 2022 Category: Drugs & Pharmacology Authors: Shirin Ardeshirrouhanifard, Huijun An, Ravi K. Goyal, Mukaila A. Raji, Jodi B. Segal, G. Caleb Alexander, Hemalkumar B. Mehta Tags: ORIGINAL RESEARCH ARTICLE Source Type: research

Po-716-07 is cha2ds2vasc score useful for predicting the risk of stroke in patients with atrial fibrillation and cancer? : a single-center observational analysis
Patients with active cancer were historically excluded from clinical trials validating the CHA2DS2VASc score for stroke prediction in atrial fibrillation (AF). Limited data have questioned the predictive value of the score in patients with cancer and AF, underscoring the need for more personalized scores for prediction of stroke in these patients.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Udhayvir S. Grewal, Mohammad Bhuiyan, Nachiket Madhav APTE, Parinita A. Dherange, Paari Dominic Source Type: research

Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure
ConclusionsThe CHF patients with history of cancer and AF had higher risk for stroke, systemic thrombosis, and major bleeding, especially in the elderly and those with IHD, but considerable number of the patients did not receive anticoagulant therapy, indicating the need for better optimal anticoagulation strategy.
Source: ESC Heart Failure - April 18, 2022 Category: Cardiology Authors: Kotaro Nochioka, Satoshi Yasuda, Yasuhiko Sakata, Takashi Shiroto, Hideka Hayashi, Jun Takahashi, Hiroyuki Takahama, Satoshi Miyata, Hiroaki Shimokawa Tags: Original Article Source Type: research

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the united states, 2010 ‐2016
ConclusionsNearly 7 out of 10 patients with cancer and NVAF did not receive anticoagulation. Use of DOACs increased from 2010 to 2016, with a corresponding decline in warfarin use. DOACs are used less than warfarin among those at higher risk of stroke.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - April 3, 2022 Category: Drugs & Pharmacology Authors: Shirin Ardeshirrouhanifard, Huijun An, Ravi K. Goyal, Mukaila A. Raji, Jodi B. Segal, G. Caleb Alexander, Hemalkumar B. Mehta Tags: RESEARCH ARTICLE Source Type: research

Vertebral artery stenosis predicts cerebrovascular diseases following radiotherapy for nasopharyngeal carcinoma
CONCLUSION: Our study found that NPC patients with vertebral artery stenosis, atrial fibrillation, or hypertension carry a higher risk for ischemic stroke or TIA. Regular assessment of vertebral artery after radiotherapy was suggested.PMID:35357575 | DOI:10.1007/s00520-022-07011-8
Source: Atherosclerosis - March 31, 2022 Category: Cardiology Authors: Chien-Fu Yeh Yu-Ching Chin Wei Hung Pin-I Huang Ming-Ying Lan Source Type: research

Management of Anticoagulation in Cancer Patients with Atrial Fibrillation
Isr Med Assoc J. 2022 Mar;24(3):183-185.ABSTRACTAtrial fibrillation is becoming an increasingly important problem in cardio-oncology. Specific risk factors for atrial fibrillation occurrence include type of cancer disease and anticancer drugs. Anticoagulation is often abandoned. The CHA2DS2-VASc and CHA2DS2 scores may be important not only in predicting stroke but also in mortality. The role of new direct oral anticoagulants is growing, but they need to be used in a personalized approach depending on the risk of unbeneficial interactions with cancer treatment and the risk of bleeding.PMID:35347933
Source: The Israel Medical Association Journal - March 29, 2022 Category: General Medicine Authors: Sebastian Szmit Jaros ław Kępski Michal Wilk Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20